Russell Frank Company’s Sucampo Pharmaceuticals, Inc. SCMP Stock Holding History

Russell Frank Company’s Portfolio SCMP Stock Details SCMP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	$2.53M	Sell	231,781 -109,870	-32%	-$1.39M	﹤0.01%	1728
2015 Q4	$6.05M	Sell	341,651 -245,436	-42%	-$4.4M	0.01%	1181
2015 Q3	$11.7M	Buy	587,087 +406,570	+225%	+$9.32M	0.02%	801
2015 Q2	$2.97M	Buy	180,517 +121,638	+207%	+$2.11M	﹤0.01%	1748
2015 Q1	$916K	Buy	+58,879	New	+$913K	﹤0.01%	2183
2014 Q4	–	Sell	-6,125	Closed	-$40K	–	3079
2014 Q3	$40K	Hold	6,125	–	–	﹤0.01%	2740
2014 Q2	$37K	Hold	6,125	–	–	﹤0.01%	2724
2014 Q1	$41K	Buy	+6,125	New	+$52.4K	﹤0.01%	2751
2013 Q4	–	Sell	-74	Closed	–	–	3240
2013 Q3	$0	Buy	74 +15	+25%	+$94	﹤0.01%	3515
2013 Q2	$0	Buy	+59	New	+$468	﹤0.01%	3385

Other funds holding SCMP

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

KAM

Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Prudential Financial Newark, New Jersey $81.2B AUM 27.81% 1-Year Est. Return

Russell Frank Company's SCMP Position: Q1 2016 in Review

Russell Frank Company reduced its Sucampo Pharmaceuticals, Inc. (SCMP) stake by 32% in Q1 2016, selling an estimated $1.39M and leaving 231,781 shares worth $2.53M. The position accounts for ﹤0.01% of the portfolio, ranked #1728.

Russell Frank Company first reported a position in SCMP in Q2 2013 and has held it in 10 quarters since. The position peaked at $11.7M in Q3 2015. 134 funds tracked by Wall St. Rank hold SCMP as of Q1 2016.

Russell Frank Company held 231,781 shares of Sucampo Pharmaceuticals, Inc. worth $2.53M as of Q1 2016.
Russell Frank Company sold 109,870 Sucampo Pharmaceuticals, Inc. shares in Q1 2016, an estimated $1.39M.
Sucampo Pharmaceuticals, Inc. made up ﹤0.01% of Russell Frank Company's portfolio in Q1 2016, its #1728 holding.
Russell Frank Company first reported a position in Sucampo Pharmaceuticals, Inc. in Q2 2013 and has held it in 10 quarters since.
Russell Frank Company's Sucampo Pharmaceuticals, Inc. position peaked at $11.7M in Q3 2015.
134 funds tracked by Wall St. Rank held Sucampo Pharmaceuticals, Inc. as of Q1 2016.

Based on Russell Frank Company's 13F filing for Q1 2016, filed 29 Apr 2016.